These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24007689)

  • 21. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
    Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
    Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
    [No Abstract]   [Full Text] [Related]  

  • 22. Reducing stigma through education to enhance Medication-Assisted Recovery.
    Woods JS; Joseph H
    J Addict Dis; 2012; 31(3):226-35. PubMed ID: 22873184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.
    Batchelder AW; Peyser D; Nahvi S; Arnsten JH; Litwin AH
    Drug Alcohol Depend; 2015 Aug; 153():66-71. PubMed ID: 26096534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing access to opioid maintenance treatment: the role of primary care in France.
    Roux P; Lions C; Carrieri MP
    Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
    [No Abstract]   [Full Text] [Related]  

  • 31. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication-assisted treatment of opiate dependence is gaining favor.
    Jerry JM; Collins GB
    Cleve Clin J Med; 2013 Jun; 80(6):345-9. PubMed ID: 23733899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone maintenance-lessons from two systems in China.
    Lee SS; Newman R
    Harm Reduct J; 2017 Sep; 14(1):66. PubMed ID: 28946906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
    Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
    Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.